A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis Source: Eur Respir J, 50 (6) 1701354; 10.1183/13993003.01354-2017 Year: 2017
Genetic diversity of M. tuberculosis isolates from patients with drug-resistant TB in Japan Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018
Study of genetic heterogeneity in Mycobacterium tuberculosis isolates from tuberculosis patients using DNA fingerprinting Source: Eur Respir J 2005; 26: Suppl. 49, 655s Year: 2005
Resistance genotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Serbia Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Simultaneous detection of XDR genetic determinants and Mycobacterium tuberculosis genotyping by TB-TEST. Source: International Congress 2017 – MDRTB: detection and management Year: 2017
Relationship between rpoB mutations and minimum inhibitory concentrations of rifampicin in multi drug resistant strains of mycobacterium tuberculosis Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011
Systematic evaluation of clarithromycin (CLA) resistance associated mutations in Mycobacterium abscessus complex based on whole-genome sequencing analysis and drug susceptibility testing. Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020
Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan Source: Eur Respir J 2009; 33: 368-374 Year: 2009
Estimation of resistance of M.tuberculosis different genotypes to disinfectants Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019
Susceptibility of Mycobacterium tuberculosis strains to fluoquinolones, obtained from chronic patients with multidrug resistant pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 315s Year: 2001
Detection of fluoroquinolones resistance mutations in mycobacterium tuberculosis by hydrolysis probes and RFLP Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013
Induction of M. tuberculosis (MTB) drug resistance (DR) mutations in HIV-infected hosts and pathways of further spread of the evolutionary successful drug-resistant MTB clonal lines Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis independent of fluoroquinolone use Source: Eur Respir J, 50 (6) 1701633; 10.1183/13993003.01633-2017 Year: 2017
Mycobacterium tuberculosis resistance Source: Eur Respir J 2002; 20: Suppl. 38, 360s Year: 2002
Genetic diversity of multidrug resistant mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran, using MIRU-VNTR technique Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016
Molecular analysis of mutations in genes associated with multidrug-resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Moscow region, Russia Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018
Characteristics of drug susceptibility testing for bedaquline and clofazimine of 178 drug-resistant Mycobacterium tuberculosis isolates in Japan Source: International Congress 2019 – Drug-resistant tuberculosis Year: 2019
Molecular epidemiology of tuberculosis Source: Eur Respir J 2002; 20: 54S-65S Year: 2002
Genetic markers of multi-drug and extensive drug resistant M. tuberculosis in Kyrgyz Republic Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools Year: 2012